SRT3657

Modify Date: 2024-02-12 21:33:56

Use of SRT3657

SRT3657 is a brain-permeable activator of SIRT1, with neuroprotective effect[1].

Name	SRT3657

Description	SRT3657 is a brain-permeable activator of SIRT1, with neuroprotective effect[1].
Related Catalog	Signaling Pathways >> Epigenetics >> Sirtuin Signaling Pathways >> Cell Cycle/DNA Damage >> Sirtuin Research Areas >> Neurological Disease
Target	SIRT1[1]
In Vivo	SRT3657 (30 mg/kg; i.g.; daily; for 6 weeks) activates SIRT1 in CK-p25 mice[1]. SRT3657 treatment prevents synaptic and neuronal loss and effectively rescues against neurodegeneration-driven memory impairments[1]. SRT3657 recapitulates the neuroprotective potential of caloric restriction (CR)[1]. Animal Model: Adult double-transgenic CK-p25 mice (3-month-old)[1] Dosage: 30 mg/kg Administration: Oral gavage, daily, for 6 weeks Result: Significantly upregulated the activity of SIRT1 in hippocampal extracts of CK-p25 animals.
References	[1]. Gräff J, et al. A dietary regimen of caloric restriction or pharmacological activation of SIRT1 to delay the onset of neurodegeneration. J Neurosci. 2013 May 22;33(21):8951-60.

Molecular Formula	C₄₀H₅₄N₈O₆S
Molecular Weight	774.97

Get all suppliers and price by the below link:

Dichloromethane
CAS#:75-09-2

Polyacrylic acid
CAS#:9003-01-4

sodium carbonate
CAS#:497-19-8

Silicon dioxide
CAS#:7631-86-9

Triethanolamine
CAS#:102-71-6

Demeton
CAS#:126-75-0

Water
CAS#:7732-18-5

Diclofenac sodium
CAS#:15307-79-6

Budesonide
CAS#:51372-29-3